Autism Spectrum Disorder Trial, Recruiting NCT04899544 Sponsor: Stanford University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT04899544
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A child who has been diagnosed with Autism Spectrum Disorder (ASD) based on recognised diagnostic tools and expert assessment
  • Children who are between 2 years and 5 years 11 months old (both boys and girls)
  • Children who are able to participate in assessment tasks well enough for valid test scores to be recorded
  • Children who have delayed language development, as measured by a specific language test — the required level of delay varies depending on the child's age (confirm exact thresholds with trial site)
  • Children who have been on a stable treatment plan — such as behaviour therapy, speech therapy, school placement, or medication — for at least one month before the study begins
  • Children whose treatment plan is not expected to change during the study period
  • Children who are receiving no more than 60 minutes of individual one-on-one speech therapy per week
  • Families where at least one parent or primary caregiver is available to consistently take part in parent training and research activities

Who may not be able to join:

  • Children who have a current or past diagnosis of a severe psychiatric condition (such as bipolar disorder)
  • Children who are currently receiving 15 hours or more per week of Applied Behaviour Analysis (ABA) therapy
  • Children who have an active or unstable medical condition, such as an unstable seizure disorder or heart disease
  • Children who have previously completed an adequate course of a specific therapy called Pivotal Response Treatment (PRT)
  • Children who live more than 30 miles from Stanford University
  • Children whose primary language at home is not English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonio Y. Hardan, MD, Stanford University

Phone: (650)736-1235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 October 2022
Est. completion
15 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Number of Child Utterances during the Parent-Child portion of the Structured Lab Observation (SLO).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov